Medifast director Parsa Kiai reports fund purchases

The reported average was $12.2417 per share; actual prices ranged from $12.205 to $12.25.

Rhea-AI Filing Summary

Medifast Inc. director Parsa Kiai reported purchases attributed to Steamboat Capital Partners Master Fund, LP (5,399 common shares) and Steamboat Capital Partners II, LP (158 common shares) on October 28, 2026, each at an average price of $12.2417 per share. Kiai may be deemed to have a pecuniary interest in the funds’ shares and disclaims beneficial ownership except to that extent. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Buyer: 5,557 shares

Net Buy 2 txns

Insider Kiai Parsa

Role Director

Bought 5,557 shs ($68K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F3, F4	5,399	$12.2417	$66K
Purchase	Common Stock F2, F3, F4	158	$12.2417	$2K

Holdings After Transaction: Common Stock — 20,428 shares (Indirect, Notes)

Footnotes (4)

1. F1. Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
2. F2. Ownership of Steamboat Capital Partners II, LP (II).
3. F3. Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai ("Kiai") is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
4. F4. This is an average price. Actual prices paid for the shares purchased on 10/28/26 and reported on this line range from $12.205 to $12.25. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Common shares purchased: 5,399 shares Common shares purchased: 158 shares Average purchase price: $12.2417 per share +1 more

4 metrics

Common shares purchased 5,399 shares Attributed to Steamboat Capital Partners Master Fund, LP; October 28, 2026

Common shares purchased 158 shares Attributed to Steamboat Capital Partners II, LP; October 28, 2026

Average purchase price $12.2417 per share Reported for the October 28, 2026 purchases

Actual purchase-price range $12.205 to $12.25 per share Prices for shares purchased on October 28, 2026

Key Terms

pecuniary interest, investment discretion, performance allocation, beneficial ownership

4 terms

pecuniary interest regulatory

"may be deemed to have a pecuniary interest in the shares"

investment discretion financial

"has delegated investment discretion to Steamboat Capital Partners, LLC"

performance allocation financial

"entitled to receive a performance allocation from each"

beneficial ownership regulatory

"disclaims beneficial ownership of securities reported hereon"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did the MED-related funds purchase?

The reported purchases were 5,399 common shares attributed to Steamboat Capital Partners Master Fund, LP and 158 common shares attributed to Steamboat Capital Partners II, LP. Both were dated October 28, 2026; no Rule 10b5-1 plan is reported.

What price did the MED-related purchases carry?

The reported average price was $12.2417 per share, and actual prices for the shares purchased on October 28, 2026 ranged from $12.205 to $12.25.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/30/2026 - 12:56 PM EDT Accepted by SEC EDGAR 10/30/2026 - 12:56 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kiai Parsa

(Last) (First) (Middle)

24 MAPLE AVE

(Street)

RYE NEW YORK 10580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MEDIFAST INC [ MED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/28/2026		P		5,399	A	$12.2417	712,891	I	Notes(1)(3)(4)
Common Stock	10/28/2026		P		158	A	$12.2417	20,428	I	Notes(2)(3)(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).

2. Ownership of Steamboat Capital Partners II, LP (II).

3. Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai ("Kiai") is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.

4. This is an average price. Actual prices paid for the shares purchased on 10/28/26 and reported on this line range from $12.205 to $12.25. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Parsa Kiai	10/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)